Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil

In 2010, a ten-valent pneumococcal conjugate vaccine (PCV10) was introduced in the routine infant national immunization program in Brazil. Invasive pneumococcal disease (IPD) caused by serotype 19A (Spn19A) increased after the introduction of PCVs in several countries. We compared the frequency, ant...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2018-11, Vol.13 (11), p.e0208211-e0208211
Hauptverfasser: Cassiolato, Ana Paula, Almeida, Samanta Cristine Grassi, Andrade, Ana Lúcia, Minamisava, Ruth, Brandileone, Maria Cristina de Cunto
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0208211
container_issue 11
container_start_page e0208211
container_title PloS one
container_volume 13
creator Cassiolato, Ana Paula
Almeida, Samanta Cristine Grassi
Andrade, Ana Lúcia
Minamisava, Ruth
Brandileone, Maria Cristina de Cunto
description In 2010, a ten-valent pneumococcal conjugate vaccine (PCV10) was introduced in the routine infant national immunization program in Brazil. Invasive pneumococcal disease (IPD) caused by serotype 19A (Spn19A) increased after the introduction of PCVs in several countries. We compared the frequency, antimicrobial resistance and molecular patterns of invasive Spn19A strains before and after PCV10 introduction in Brazil using data from the national laboratory-based surveillance. We analyzed invasive Spn19A strains isolated from 2005-2009 (pre-PCV10 period), 2011-2015 and 2016-2017 (post-PCV10 periods). Antimicrobial susceptibility was performed for all Spn19A strains, and multilocus sequence typing (MLST) was performed for strains isolated in the age groups
doi_str_mv 10.1371/journal.pone.0208211
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2139591805</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A563792353</galeid><doaj_id>oai_doaj_org_article_2300a971afb4477f9e8cc137f9d8208a</doaj_id><sourcerecordid>A563792353</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6731-a8f7a5d98698d53956095735bb4a1ecda6b26517d6d599a8362569b7a80c34543</originalsourceid><addsrcrecordid>eNqNk1Fr1TAYhosobk7_gWhAEL04x6Rp0-ZGmGPqYDBw6m34Tpr25JAmNUkPm7_NH2e6040d2YX0oiV53vdNvq9flr0keEloRT5s3OgtmOXgrFriHNc5IY-yQ8JpvmA5po_vfR9kz0LYYFzSmrGn2QHFBWc5Z4fZn9OrAWzQziLXorhWqB9N1I0fu4VXQYcINiJpXIpC0vWDUVeI5hhB72yHtN1C0FuFLqNXQ3TSSTkGNFg1pn0NCgXlXbweFCL8GEEblb9J0TZ614wyzsmAorKLLRiV4nbyyesm1G7GDqJCW5BS20mLPnn4rc3z7EkLJqgX8_so-_H59PvJ18X5xZezk-PzhWQVJQuo2wrKhteM101JeckwLytarlYFECUbYKuclaRqWFNyDjVlecn4qoIaS1qUBT3KXu98B-OCmAsfRE6SFyd1KutRdrYjGgcbMXjdg78WDrS4WXC-E-CjlkaJnGIMvCLQroqiqlquailTR1ve1KmLkLw-zmnjqleNTBXxYPZM93esXovObQXLWUFKnAzezQbe_RpViKLXQSpjwCo3TucuCC4YLuqEvvkHffh2M9Wl_ghtW5dy5WQqjktGK57TkiZq-QCVnkb1OnVRtTqt7wne7wkSE9VV7GAMQZxdfvt_9uLnPvv2HrtWYOI6ODNO_1rYB4sdKL0Lwav2rsgEi2nIbqshpiET85Al2av7DboT3U4V_QvLeyR5</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2139591805</pqid></control><display><type>article</type><title>Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Cassiolato, Ana Paula ; Almeida, Samanta Cristine Grassi ; Andrade, Ana Lúcia ; Minamisava, Ruth ; Brandileone, Maria Cristina de Cunto</creator><contributor>Hiller, N.Luisa</contributor><creatorcontrib>Cassiolato, Ana Paula ; Almeida, Samanta Cristine Grassi ; Andrade, Ana Lúcia ; Minamisava, Ruth ; Brandileone, Maria Cristina de Cunto ; Hiller, N.Luisa</creatorcontrib><description>In 2010, a ten-valent pneumococcal conjugate vaccine (PCV10) was introduced in the routine infant national immunization program in Brazil. Invasive pneumococcal disease (IPD) caused by serotype 19A (Spn19A) increased after the introduction of PCVs in several countries. We compared the frequency, antimicrobial resistance and molecular patterns of invasive Spn19A strains before and after PCV10 introduction in Brazil using data from the national laboratory-based surveillance. We analyzed invasive Spn19A strains isolated from 2005-2009 (pre-PCV10 period), 2011-2015 and 2016-2017 (post-PCV10 periods). Antimicrobial susceptibility was performed for all Spn19A strains, and multilocus sequence typing (MLST) was performed for strains isolated in the age groups &lt;5 years and ≥50 years. Among the study period, a total of 9,852 invasive Spn strains were analyzed, and 673 (6.8%) belonged to serotype 19A. Overall, the proportion of Spn19A among the total number of IPD strains increased from 2.8% in 2005-2009 to 7.0% and 16.4% in 2011-2015 and 2016-2017, respectively. The relative increase in Spn19A was observed especially in children &lt;5 years old (2005-2009: 3.2%; 2011-2015: 15.5%; 2016-2017: 31.2%). The percentage of penicillin resistance (MIC 2.0-4.0 μg/mL), erythromycin resistance and multidrug resistance (MDR) increased after PCV10 introduction due to the expansion of the MDR clonal complex CC320 (2005-2009: 8.6%; 2011-2015: 56.1%; 2016-2017: 66.5%). We observed an expansion of MDR-CC320 among invasive Spn19A strains after PCV10 introduction in Brazil, probably related to a combination of factors, such as vaccination and antimicrobial pressure. Continued surveillance of Spn19A strains is necessary to monitor the sustainability of this clonal complex in the Brazilian population.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0208211</identifier><identifier>PMID: 30496296</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adolescent ; Adult ; Anti-Bacterial Agents - pharmacology ; Antibacterial agents ; Antibiotics ; Antiinfectives and antibacterials ; Antimicrobial agents ; Antimicrobial resistance ; Bacterial Typing Techniques ; Biology and Life Sciences ; Brazil - epidemiology ; Child ; Child, Preschool ; Children ; Conjugates ; Drug resistance ; Drug Resistance, Bacterial ; Drug Resistance, Multiple ; Elderly ; Erythromycin ; Expansion ; Health aspects ; Humans ; Immunization ; Laboratories ; Medicine and Health Sciences ; Microbial drug resistance ; Middle Aged ; Multidrug resistance ; Multidrug resistant organisms ; Multilocus Sequence Typing ; Penicillin ; Penicillins ; People and Places ; Pneumococcal infections ; Pneumococcal Infections - drug therapy ; Pneumococcal Infections - epidemiology ; Pneumococcal Infections - prevention &amp; control ; Pneumococcal Vaccines - therapeutic use ; Pneumonia ; Risk factors ; Serogroup ; Streptococcus infections ; Streptococcus pneumoniae ; Streptococcus pneumoniae - drug effects ; Streptococcus pneumoniae - genetics ; Streptococcus pneumoniae - isolation &amp; purification ; Surveillance ; Sustainability ; Sustainable development ; Vaccination ; Vaccines ; Young Adult</subject><ispartof>PloS one, 2018-11, Vol.13 (11), p.e0208211-e0208211</ispartof><rights>COPYRIGHT 2018 Public Library of Science</rights><rights>2018 Cassiolato et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2018 Cassiolato et al 2018 Cassiolato et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6731-a8f7a5d98698d53956095735bb4a1ecda6b26517d6d599a8362569b7a80c34543</citedby><cites>FETCH-LOGICAL-c6731-a8f7a5d98698d53956095735bb4a1ecda6b26517d6d599a8362569b7a80c34543</cites><orcidid>0000-0002-7254-9102 ; 0000-0001-5007-5383</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264150/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264150/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,2103,2929,23871,27929,27930,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30496296$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Hiller, N.Luisa</contributor><creatorcontrib>Cassiolato, Ana Paula</creatorcontrib><creatorcontrib>Almeida, Samanta Cristine Grassi</creatorcontrib><creatorcontrib>Andrade, Ana Lúcia</creatorcontrib><creatorcontrib>Minamisava, Ruth</creatorcontrib><creatorcontrib>Brandileone, Maria Cristina de Cunto</creatorcontrib><title>Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>In 2010, a ten-valent pneumococcal conjugate vaccine (PCV10) was introduced in the routine infant national immunization program in Brazil. Invasive pneumococcal disease (IPD) caused by serotype 19A (Spn19A) increased after the introduction of PCVs in several countries. We compared the frequency, antimicrobial resistance and molecular patterns of invasive Spn19A strains before and after PCV10 introduction in Brazil using data from the national laboratory-based surveillance. We analyzed invasive Spn19A strains isolated from 2005-2009 (pre-PCV10 period), 2011-2015 and 2016-2017 (post-PCV10 periods). Antimicrobial susceptibility was performed for all Spn19A strains, and multilocus sequence typing (MLST) was performed for strains isolated in the age groups &lt;5 years and ≥50 years. Among the study period, a total of 9,852 invasive Spn strains were analyzed, and 673 (6.8%) belonged to serotype 19A. Overall, the proportion of Spn19A among the total number of IPD strains increased from 2.8% in 2005-2009 to 7.0% and 16.4% in 2011-2015 and 2016-2017, respectively. The relative increase in Spn19A was observed especially in children &lt;5 years old (2005-2009: 3.2%; 2011-2015: 15.5%; 2016-2017: 31.2%). The percentage of penicillin resistance (MIC 2.0-4.0 μg/mL), erythromycin resistance and multidrug resistance (MDR) increased after PCV10 introduction due to the expansion of the MDR clonal complex CC320 (2005-2009: 8.6%; 2011-2015: 56.1%; 2016-2017: 66.5%). We observed an expansion of MDR-CC320 among invasive Spn19A strains after PCV10 introduction in Brazil, probably related to a combination of factors, such as vaccination and antimicrobial pressure. Continued surveillance of Spn19A strains is necessary to monitor the sustainability of this clonal complex in the Brazilian population.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibacterial agents</subject><subject>Antibiotics</subject><subject>Antiinfectives and antibacterials</subject><subject>Antimicrobial agents</subject><subject>Antimicrobial resistance</subject><subject>Bacterial Typing Techniques</subject><subject>Biology and Life Sciences</subject><subject>Brazil - epidemiology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Conjugates</subject><subject>Drug resistance</subject><subject>Drug Resistance, Bacterial</subject><subject>Drug Resistance, Multiple</subject><subject>Elderly</subject><subject>Erythromycin</subject><subject>Expansion</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Immunization</subject><subject>Laboratories</subject><subject>Medicine and Health Sciences</subject><subject>Microbial drug resistance</subject><subject>Middle Aged</subject><subject>Multidrug resistance</subject><subject>Multidrug resistant organisms</subject><subject>Multilocus Sequence Typing</subject><subject>Penicillin</subject><subject>Penicillins</subject><subject>People and Places</subject><subject>Pneumococcal infections</subject><subject>Pneumococcal Infections - drug therapy</subject><subject>Pneumococcal Infections - epidemiology</subject><subject>Pneumococcal Infections - prevention &amp; control</subject><subject>Pneumococcal Vaccines - therapeutic use</subject><subject>Pneumonia</subject><subject>Risk factors</subject><subject>Serogroup</subject><subject>Streptococcus infections</subject><subject>Streptococcus pneumoniae</subject><subject>Streptococcus pneumoniae - drug effects</subject><subject>Streptococcus pneumoniae - genetics</subject><subject>Streptococcus pneumoniae - isolation &amp; purification</subject><subject>Surveillance</subject><subject>Sustainability</subject><subject>Sustainable development</subject><subject>Vaccination</subject><subject>Vaccines</subject><subject>Young Adult</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk1Fr1TAYhosobk7_gWhAEL04x6Rp0-ZGmGPqYDBw6m34Tpr25JAmNUkPm7_NH2e6040d2YX0oiV53vdNvq9flr0keEloRT5s3OgtmOXgrFriHNc5IY-yQ8JpvmA5po_vfR9kz0LYYFzSmrGn2QHFBWc5Z4fZn9OrAWzQziLXorhWqB9N1I0fu4VXQYcINiJpXIpC0vWDUVeI5hhB72yHtN1C0FuFLqNXQ3TSSTkGNFg1pn0NCgXlXbweFCL8GEEblb9J0TZ614wyzsmAorKLLRiV4nbyyesm1G7GDqJCW5BS20mLPnn4rc3z7EkLJqgX8_so-_H59PvJ18X5xZezk-PzhWQVJQuo2wrKhteM101JeckwLytarlYFECUbYKuclaRqWFNyDjVlecn4qoIaS1qUBT3KXu98B-OCmAsfRE6SFyd1KutRdrYjGgcbMXjdg78WDrS4WXC-E-CjlkaJnGIMvCLQroqiqlquailTR1ve1KmLkLw-zmnjqleNTBXxYPZM93esXovObQXLWUFKnAzezQbe_RpViKLXQSpjwCo3TucuCC4YLuqEvvkHffh2M9Wl_ghtW5dy5WQqjktGK57TkiZq-QCVnkb1OnVRtTqt7wne7wkSE9VV7GAMQZxdfvt_9uLnPvv2HrtWYOI6ODNO_1rYB4sdKL0Lwav2rsgEi2nIbqshpiET85Al2av7DboT3U4V_QvLeyR5</recordid><startdate>20181129</startdate><enddate>20181129</enddate><creator>Cassiolato, Ana Paula</creator><creator>Almeida, Samanta Cristine Grassi</creator><creator>Andrade, Ana Lúcia</creator><creator>Minamisava, Ruth</creator><creator>Brandileone, Maria Cristina de Cunto</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-7254-9102</orcidid><orcidid>https://orcid.org/0000-0001-5007-5383</orcidid></search><sort><creationdate>20181129</creationdate><title>Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil</title><author>Cassiolato, Ana Paula ; Almeida, Samanta Cristine Grassi ; Andrade, Ana Lúcia ; Minamisava, Ruth ; Brandileone, Maria Cristina de Cunto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6731-a8f7a5d98698d53956095735bb4a1ecda6b26517d6d599a8362569b7a80c34543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibacterial agents</topic><topic>Antibiotics</topic><topic>Antiinfectives and antibacterials</topic><topic>Antimicrobial agents</topic><topic>Antimicrobial resistance</topic><topic>Bacterial Typing Techniques</topic><topic>Biology and Life Sciences</topic><topic>Brazil - epidemiology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Conjugates</topic><topic>Drug resistance</topic><topic>Drug Resistance, Bacterial</topic><topic>Drug Resistance, Multiple</topic><topic>Elderly</topic><topic>Erythromycin</topic><topic>Expansion</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Immunization</topic><topic>Laboratories</topic><topic>Medicine and Health Sciences</topic><topic>Microbial drug resistance</topic><topic>Middle Aged</topic><topic>Multidrug resistance</topic><topic>Multidrug resistant organisms</topic><topic>Multilocus Sequence Typing</topic><topic>Penicillin</topic><topic>Penicillins</topic><topic>People and Places</topic><topic>Pneumococcal infections</topic><topic>Pneumococcal Infections - drug therapy</topic><topic>Pneumococcal Infections - epidemiology</topic><topic>Pneumococcal Infections - prevention &amp; control</topic><topic>Pneumococcal Vaccines - therapeutic use</topic><topic>Pneumonia</topic><topic>Risk factors</topic><topic>Serogroup</topic><topic>Streptococcus infections</topic><topic>Streptococcus pneumoniae</topic><topic>Streptococcus pneumoniae - drug effects</topic><topic>Streptococcus pneumoniae - genetics</topic><topic>Streptococcus pneumoniae - isolation &amp; purification</topic><topic>Surveillance</topic><topic>Sustainability</topic><topic>Sustainable development</topic><topic>Vaccination</topic><topic>Vaccines</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cassiolato, Ana Paula</creatorcontrib><creatorcontrib>Almeida, Samanta Cristine Grassi</creatorcontrib><creatorcontrib>Andrade, Ana Lúcia</creatorcontrib><creatorcontrib>Minamisava, Ruth</creatorcontrib><creatorcontrib>Brandileone, Maria Cristina de Cunto</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cassiolato, Ana Paula</au><au>Almeida, Samanta Cristine Grassi</au><au>Andrade, Ana Lúcia</au><au>Minamisava, Ruth</au><au>Brandileone, Maria Cristina de Cunto</au><au>Hiller, N.Luisa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2018-11-29</date><risdate>2018</risdate><volume>13</volume><issue>11</issue><spage>e0208211</spage><epage>e0208211</epage><pages>e0208211-e0208211</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>In 2010, a ten-valent pneumococcal conjugate vaccine (PCV10) was introduced in the routine infant national immunization program in Brazil. Invasive pneumococcal disease (IPD) caused by serotype 19A (Spn19A) increased after the introduction of PCVs in several countries. We compared the frequency, antimicrobial resistance and molecular patterns of invasive Spn19A strains before and after PCV10 introduction in Brazil using data from the national laboratory-based surveillance. We analyzed invasive Spn19A strains isolated from 2005-2009 (pre-PCV10 period), 2011-2015 and 2016-2017 (post-PCV10 periods). Antimicrobial susceptibility was performed for all Spn19A strains, and multilocus sequence typing (MLST) was performed for strains isolated in the age groups &lt;5 years and ≥50 years. Among the study period, a total of 9,852 invasive Spn strains were analyzed, and 673 (6.8%) belonged to serotype 19A. Overall, the proportion of Spn19A among the total number of IPD strains increased from 2.8% in 2005-2009 to 7.0% and 16.4% in 2011-2015 and 2016-2017, respectively. The relative increase in Spn19A was observed especially in children &lt;5 years old (2005-2009: 3.2%; 2011-2015: 15.5%; 2016-2017: 31.2%). The percentage of penicillin resistance (MIC 2.0-4.0 μg/mL), erythromycin resistance and multidrug resistance (MDR) increased after PCV10 introduction due to the expansion of the MDR clonal complex CC320 (2005-2009: 8.6%; 2011-2015: 56.1%; 2016-2017: 66.5%). We observed an expansion of MDR-CC320 among invasive Spn19A strains after PCV10 introduction in Brazil, probably related to a combination of factors, such as vaccination and antimicrobial pressure. Continued surveillance of Spn19A strains is necessary to monitor the sustainability of this clonal complex in the Brazilian population.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>30496296</pmid><doi>10.1371/journal.pone.0208211</doi><tpages>e0208211</tpages><orcidid>https://orcid.org/0000-0002-7254-9102</orcidid><orcidid>https://orcid.org/0000-0001-5007-5383</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2018-11, Vol.13 (11), p.e0208211-e0208211
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2139591805
source MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS) Journals Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Adolescent
Adult
Anti-Bacterial Agents - pharmacology
Antibacterial agents
Antibiotics
Antiinfectives and antibacterials
Antimicrobial agents
Antimicrobial resistance
Bacterial Typing Techniques
Biology and Life Sciences
Brazil - epidemiology
Child
Child, Preschool
Children
Conjugates
Drug resistance
Drug Resistance, Bacterial
Drug Resistance, Multiple
Elderly
Erythromycin
Expansion
Health aspects
Humans
Immunization
Laboratories
Medicine and Health Sciences
Microbial drug resistance
Middle Aged
Multidrug resistance
Multidrug resistant organisms
Multilocus Sequence Typing
Penicillin
Penicillins
People and Places
Pneumococcal infections
Pneumococcal Infections - drug therapy
Pneumococcal Infections - epidemiology
Pneumococcal Infections - prevention & control
Pneumococcal Vaccines - therapeutic use
Pneumonia
Risk factors
Serogroup
Streptococcus infections
Streptococcus pneumoniae
Streptococcus pneumoniae - drug effects
Streptococcus pneumoniae - genetics
Streptococcus pneumoniae - isolation & purification
Surveillance
Sustainability
Sustainable development
Vaccination
Vaccines
Young Adult
title Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T07%3A02%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expansion%20of%20the%20multidrug-resistant%20clonal%20complex%20320%20among%20invasive%20Streptococcus%20pneumoniae%20serotype%2019A%20after%20the%20introduction%20of%20a%20ten-valent%20pneumococcal%20conjugate%20vaccine%20in%20Brazil&rft.jtitle=PloS%20one&rft.au=Cassiolato,%20Ana%20Paula&rft.date=2018-11-29&rft.volume=13&rft.issue=11&rft.spage=e0208211&rft.epage=e0208211&rft.pages=e0208211-e0208211&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0208211&rft_dat=%3Cgale_plos_%3EA563792353%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2139591805&rft_id=info:pmid/30496296&rft_galeid=A563792353&rft_doaj_id=oai_doaj_org_article_2300a971afb4477f9e8cc137f9d8208a&rfr_iscdi=true